Skip to main content
Clinical Trials/NCT06249711
NCT06249711
Withdrawn
Phase 1

Noninvasive Targeted Neuromodulation for Treatment of Food Addiction

University of Utah1 site in 1 country40 target enrollmentMarch 3, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Overweight
Sponsor
University of Utah
Enrollment
40
Locations
1
Primary Endpoint
Change in body weight (%) from baseline week 0 to week 16
Status
Withdrawn
Last Updated
11 months ago

Overview

Brief Summary

This study will evaluate a new form of non-invasive deep brain therapy for food addiction. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled trial. The trial will evaluate brain target engagement using magnetic resonance imaging, Food Cravings Questionnaire-State, and changes in subject's weight over the course of the study.

Registry
clinicaltrials.gov
Start Date
March 3, 2024
End Date
March 3, 2024
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jan Kubanek

Assistant Professor

University of Utah

Eligibility Criteria

Inclusion Criteria

  • History of at least one self-reported unsuccessful dietary effort to lose body weight
  • Body mass index more than or equal to 30 kg/m\^2 or more than or equal to 25 kg/m\^2 with the presence of at least one of the following weight-related comorbidities: hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease.

Exclusion Criteria

  • Lifetime history of a serious suicide attempt
  • MRI intolerance or contraindication
  • Pregnant or breast feeding
  • Diabetic (HbA1c more than 48 mmol/mol or 6.5%)
  • A self-reported change in body weight more than 10 lbs within 60 days before screening
  • Clinically inappropriate for participation in the study as determined by the study team

Outcomes

Primary Outcomes

Change in body weight (%) from baseline week 0 to week 16

Time Frame: The body weight will be taken prior to each intervention (once per week)

The body weight will be quantified with respect to baseline (100%), taken prior to the first intervention.

Number of participants who achieved body weight reduction >= 5%

Time Frame: Assessment at week 16

Proportion of subjects who have lost at least 5% of their weight at week 16 relative to the baseline week 0.

Food Cravings Questionnaire-State

Time Frame: During and immediately after each weekly intervention

This 15-item questionnaire measures immediate level of food craving, each item ranging from 1 (strongly disagree) to 5 (strongly agree). Higher total scores indicate stronger desire to eat.

Hamilton Depression Rating Scale, 17 item

Time Frame: For up to 16 weeks

This 17-item questionnaire measures the severity of depression. Scores range between 0 (least severe) to 52 (most severe).

Study Sites (1)

Loading locations...

Similar Trials